By Linda Naa Deide AryeeteyCape Town, March 6, GNA – The World Health Organisation (WHO) General Special Envoy on Chronic ...
Opportunities in the asthma market include the growth driven by innovative therapies like dexpramipexole and depemokimab, expanding patient pools due to rising asthma prevalence, and increased ...